Skip to main content

Agora
Sign in

House bill · H.R. 10150 (119th Congress)

To amend the Federal Food, Drug, and Cosmetic Act to provide a period of market exclusivity for botanical drugs, and for other purposes.

U.S. House of Representatives

Latest action Aug 27, 2026

Sponsor: Lauren Boebert (U.S. Representative, CO-4, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Sep 7, 2026. About our data

Summary

This bill would grant 12 years of market exclusivity to botanical drugs approved by the Food and Drug Administration after enactment.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Full history

  1. Aug 27, 2026

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Aug 27, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Aug 27, 2026

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

Read the record